blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3086813

EP3086813 - MTG SUBSTRATES FOR COVALENT CONJUGATION OF COMPOUNDS [Right-click to bookmark this link]
Former [2016/44]mTG SUBSTRATES FOR COVALENT CONJUGATION OF COMPOUNDS
[2022/13]
StatusNo opposition filed within time limit
Status updated on  12.04.2024
Database last updated on 29.06.2024
FormerThe patent has been granted
Status updated on  05.05.2023
FormerGrant of patent is intended
Status updated on  08.09.2022
FormerExamination is in progress
Status updated on  01.08.2022
FormerGrant of patent is intended
Status updated on  23.03.2022
FormerExamination is in progress
Status updated on  24.02.2020
Most recent event   Tooltip12.04.2024No opposition filed within time limitpublished on 15.05.2024  [2024/20]
Applicant(s)For all designated states
Covalab
11 Avenue Albert Einstein
69100 Villeurbanne / FR
[2016/44]
Inventor(s)01 / EL ALAOUI, Saïd
14 rue Philippe Chat
F-69750 Saint Bonnet De Mure / FR
02 / THOMAS, Vincent
c/o Covalab
11 avenue Albert Einstein
F-69100 Villeurbanne / FR
 [2023/23]
Former [2016/44]01 / EL ALAOUI, Saïd
14 rue Philippe Chat
F-69750 Saint Bonnet De Mure / FR
02 / THOMAS, Vincent
c/o COVALAB
11 avenue Albert Einstein
F-69100 Villeurbanne / FR
Representative(s)Plasseraud IP
235 Cours Lafayette
69006 Lyon / FR
[2023/23]
Former [2016/44]Cabinet Plasseraud
235 Cours Lafayette
69006 Lyon / FR
Application number, filing date14819031.723.12.2014
[2016/44]
WO2014EP79278
Priority number, dateEP2013030684723.12.2013         Original published format: EP 13306847
EP2014030554814.04.2014         Original published format: EP 14305548
[2016/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015097267
Date:02.07.2015
Language:EN
[2015/26]
Type: A1 Application with search report 
No.:EP3086813
Date:02.11.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 02.07.2015 takes the place of the publication of the European patent application.
[2016/44]
Type: B1 Patent specification 
No.:EP3086813
Date:07.06.2023
Language:EN
[2023/23]
Type: B9 Corrected patent specification 
No.:EP3086813
Date:27.09.2023
[2023/39]
Search report(s)International search report - published on:EP02.07.2015
ClassificationIPC:A61K47/65, A61K47/68, C07K7/06, C07K7/08, C07K16/00
[2022/13]
CPC:
A61K47/6889 (EP,US); A61K47/65 (EP,US); A61K47/6811 (EP);
A61K47/6855 (EP); C07K16/00 (US); C07K7/06 (US);
C07K7/08 (US); C07K2319/00 (US) (-)
Former IPC [2016/44]A61K47/48, C07K7/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/44]  
Extension statesBANot yet paid
MENot yet paid
TitleGerman:MTG-SUBSTRATE ZUR KOVALENTEN KONJUGATION VON VERBINDUNGEN[2016/44]
English:MTG SUBSTRATES FOR COVALENT CONJUGATION OF COMPOUNDS[2022/13]
French:SUBSTRATS MTG POUR CONJUGAISON COVALENTE DE COMPOSÉS[2022/13]
Former [2016/44]mTG SUBSTRATES FOR COVALENT CONJUGATION OF COMPOUNDS
Former [2016/44]SUBSTRATS MTG POUR LA CONJUGAISON COVALENTE DE COMPOSÉS
Entry into regional phase21.07.2016National basic fee paid 
21.07.2016Designation fee(s) paid 
21.07.2016Examination fee paid 
Examination procedure21.07.2016Amendment by applicant (claims and/or description)
21.07.2016Examination requested  [2016/44]
27.02.2020Despatch of a communication from the examining division (Time limit: M06)
08.09.2020Reply to a communication from the examining division
24.03.2022Communication of intention to grant the patent
28.07.2022Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
09.09.2022Communication of intention to grant the patent
04.01.2023Fee for grant paid
04.01.2023Fee for publishing/printing paid
04.01.2023Receipt of the translation of the claim(s)
Opposition(s)08.03.2024No opposition filed within time limit [2024/20]
Fees paidRenewal fee
26.10.2016Renewal fee patent year 03
31.10.2017Renewal fee patent year 04
17.10.2018Renewal fee patent year 05
25.10.2019Renewal fee patent year 06
17.11.2020Renewal fee patent year 07
14.10.2021Renewal fee patent year 08
04.11.2022Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCZ07.06.2023
HR07.06.2023
PL07.06.2023
RO07.06.2023
RS07.06.2023
SK07.06.2023
SM07.06.2023
NO07.09.2023
GR08.09.2023
IS07.10.2023
[2024/10]
Former [2024/09]CZ07.06.2023
HR07.06.2023
RS07.06.2023
SK07.06.2023
SM07.06.2023
NO07.09.2023
GR08.09.2023
IS07.10.2023
Former [2024/08]HR07.06.2023
RS07.06.2023
SK07.06.2023
SM07.06.2023
NO07.09.2023
GR08.09.2023
Former [2023/51]HR07.06.2023
RS07.06.2023
NO07.09.2023
GR08.09.2023
Former [2023/50]NO07.09.2023
GR08.09.2023
Former [2023/48]NO07.09.2023
Cited inInternational search[X]US2008234183  (HALLBRINK MATTIAS [SE], et al) [X] 1-4,12,13 * page 12, paragraphs 111-113, 130 * * page 13, paragraph 127 *;
 [AD]WO2013092983  (INNATE PHARMA [FR], et al) [AD] 1-16* the whole document *;
 [X]US2013230543  (PONS JAUME [US], et al) [X] 1,2,4,5,7-13,15,16 * page 1, paragraph 2 * * page 15, paragraph 131 - paragraph 144 * * page 34 * * page 5, paragraph 34 * * pages 61, 62 * * page 34, paragraph 216 * * page 46 - page 47; examples 9-11 * * page 12, paragraph 103 * * page 34, paragraph 210 *;
 [X]  - KAMIYA NORIHO ET AL, "Site-specific cross-linking of functional proteins by transglutamination.", ENZYME AND MICROBIAL TECHNOLOGY, (20030910), vol. 33, no. 4, ISSN 0141-0229, pages 492 - 496, XP002725332 [X] 1,2,4,5,7-9,11-13 * abstract * * page 493 * * page 492, column left * * page 494 - page 495 *

DOI:   http://dx.doi.org/10.1016/S0141-0229(03)00154-6
 [X]  - LIN CHI-WANG ET AL, "Transglutaminase-catalyzed site-specific conjugation of small-molecule probes to proteins in vitro and on the surface of living cells", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (200604), vol. 128, no. 14, ISSN 0002-7863, pages 4542 - 4543, XP002725333 [X] 1,4,7,8,11,12 * page 4542; figure 1 *

DOI:   http://dx.doi.org/10.1021/ja0604111
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.